CareDx to Report Third Quarter 2020 Financial Results
CareDx, Inc. (Nasdaq: CDNA) will release its third-quarter 2020 financial results on October 29, 2020, after market close. The conference call to review these results will be hosted by CEO Peter Maag and CFO Michael Bell at 1:30 PM PT. Interested parties can join the call by dialing 877-705-6003 or via webcast on CareDx's investor relations page. A replay will be available from October 29 at 4:30 PM PT until November 12, 2020. CareDx specializes in precision medicine for transplant patients.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that it will release financial results for the third quarter 2020 after the close of trading on Thursday, October 29, 2020. Peter Maag, Chief Executive Officer, and Michael Bell, Chief Financial Officer, will host a conference call to review the Company’s results beginning at 1:30pm PT/4:30pm ET.
Individuals interested in listening to the conference call may do so by dialing 877-705-6003 for domestic callers or 201-493-6725 for international callers. Please reference Conference ID: 13711048. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: www.CareDx.com.
A replay of the call will be available beginning October 29, 2020, at 4:30pm PT/7:30pm ET through 8:59pm PT/11:59pm ET on November 12, 2020. To access the replay, dial-in 1-844-512-2921 or 1-412-317-6671 and reference Conference ID: 13711048. The webcast will also be available on CareDx’s website for one year following the completion of the call.
About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
CONTACTS:
Greg Chodaczek
347-620-7010
investor@caredx.com
FAQ
When will CareDx release its Q3 2020 financial results?
What time is the CareDx Q3 2020 earnings call?
How can I access the CareDx earnings call?
Is there a replay available for the CareDx earnings call?
What is the conference ID for the CareDx earnings call?
